Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance

HERBALIFE LTD.

2025-Q1 EPS reported $0.49 revenue$1,221,700,000

Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.
Net income $50.4M; adjusted net income $59.9M; diluted EPS $0.49, adjusted diluted EPS $0.59.
Adjusted EBITDA $164.9M exceeds guidance; margin up 260 bps vs Q1 '24; leverage ratio reduced to 3.0x.
Full-year 2025 guidance revised: net sales range narrowed, adjusted EBITDA raised, capex reduced.
Completed acquisitions of Pro2col Health and Pruvit Ventures; formed HBL Link Bioscience with 51% ownership.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.